Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice

Hepatology

Volumn 42, Issue 3, 2005, Pages 568-577

  You, Min ^a,b   Considine, Robert V ^a   Leone, Teresa C ^c   Kelly, Daniel P ^c   Crabb, David W ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADIPONECTIN; LIVER ENZYME; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE; RECOMBINANT ADIPONECTIN; SATURATED FATTY ACID; STEARIC ACID; UNCLASSIFIED DRUG;

ADIPOCYTE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLIC FATTY LIVER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FATTY ACID OXIDATION; FATTY LIVER; MALE; MOUSE; NONHUMAN; NUTRITION; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

3-HYDROXYBUTYRIC ACID; ACETYL-COA CARBOXYLASE; ADIPONECTIN; ANIMALS; CHOLESTEROL; DIETARY FATS; DISEASE MODELS, ANIMAL; ETHANOL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PPAR ALPHA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRIGLYCERIDES;

EID: 24144496133     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20821     Document Type: Article

References (39)

1. Diehl AM. Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. Alcohol Clin Exp Res 2001;2(5 Suppl ISBRA):5:8S-14S.
2. Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NFkappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol 2001;281:G382-G392.
3. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989;13:15-19.
4. Mezey E. Dietary fat and alcoholic liver disease. HEPATOLOGY 1998;28: 901-905.
5. Nanji AA, Sadrzadeh SM, Yang EK, Fogt F, Meydani M, Dannenberg AJ. Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 1995;109:547-554.
6. Nanji AA, Satoh S, Uetake S, Ohata M, Nakajima H, Yamauchi M. Effect of type of dietary fat and ethanol on hepatic leukotriene level in experimental alcoholic liver disease. Nihon Arukoru Yakubutsu Igakkai Zasshi 2003;38:350-363.
7. Ronis MJ, Korourian S, Zipperman M, Hakkak R, Badger TM. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J Nutr 2004;134:904-912.
8. Nanji AA, Yang EK, Fogt F, Sadrzadeh SM, Dannenberg AJ. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 1996;277:1694-1700.
9. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 2001;299:638-644.
10. Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, et al. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alpha and reverse fibrosis in alcohol-induced liver disease in the rat. HEPATOLOGY 1997;26:1538-1545.
11. Nanji AA. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004;34:21-25.
12. You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gasteroenterology 2004;127:1798-1808.
13. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 2001;276:68-75.
14. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator- activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003;278:27997-28004.
15. Nanji AA, Dannenberg AJ, Jokelainen K, Bass NM. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. J Pharmacol Exp Ther 2004;310:417-424.
16. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kira S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-769.
17. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V, et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 2003;100:14217-14222.
18. Kershaw EE, Fliet JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
19. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91-100.
20. Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, Oka A, et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 2004;126:873-885.
21. Ohata M, Suzuki H, Sakamoto K, Hashimoto K, Nakajima H, Yamauchi M, et al. Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha. Alcohol Clin Exp Res 2004;28(8 Suppl Proceedings):139S-144S.
22. Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, et al. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated recepror-gamma, pioglitazone. J Pharmacol Exp Ther 2003;306:846-854.
23. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
24. Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T, Heine RJ, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 2004;27:184-189.
25. Shai I, Rimm EB, Schulze MB, Rifai N, Stampfer MJ, Hu FB. Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia 2004;47:1760-1767.
26. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005;81:780-786.
27. Schaeffet PJ, Wende AR, Magee CJ, Neilson JR, Leone TC, Chen F, et al. Calcineurin and calcium/calmodulin dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle. J Biol Chem 2004;279:39593-39603.
28. Lieber CS, DeCarli LM, Sorrell MF. Experimental methods of ethanol administration. HEPATOLOGY 1989;10:501-510.
29. Van Harken DR, Dixon CW, Heimberg M. Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J Biol Chem 1969;244:2278-2285.
30. Nicolas JM, Fernandez-Sola J, Fatjo F, Casamitjana R, Bataller R, Sacanella E, et al. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res 2001;25:83-88.
31. Ji C, Kaplowitz N. Became decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003;124:1488-1499.
32. Esfandiari F, Villanueva JA, Wong DH, French SW, Halsted CH. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol 2005;289:G54-G63.
33. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003;24:78-90.
34. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000;20:1868-1876.
35. Lin HZ, Yang SQ, Zeldin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res 1998;22:231S-237S.
36. Sparagna GC, Jones CE, Hickson-Bick DL. Attenuation of fatty acid-induced apoptosis by low dose alcohol in neonatal rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2004;287:H2209-H2215.
37. Piquet MA, Roulet M, Nogueira V, Filippi C, Sibille B, Hourmand-Ollivier I, et al. Polyunsaturated fatty acid deficiency reverses effects of alcohol on mitochondrial energy metabolism. J Hepatol 2004;41:721-729.
38. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999;354:141-148.
39. Everett L, Galli A, Crabb D. The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease. Liver 2000;20:191-199.